Metformin Exerts Anti-inflammatory and Mucus Barrier Protective Effects by Enriching Akkermansia muciniphila in Mice With Ulcerative Colitis

Haoran Ke(Nanfang Hospital), Ye Chen(Nanfang Hospital), Zitong Li(Commonwealth Scientific and Industrial Research Organisation), Siqi Wang(Nanfang Hospital), Wenlin Deng(Sun Yat-sen University), Fang Li(China Pharmaceutical University), Pinjing Lv(Nanfang Hospital)
Frontiers in Pharmacology
September 30, 2021
10.3389/fphar.2021.726707
Cited by 85

Related Papers

Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)
|Journal of Clinical Oncology|2021|350
Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction
|mSystems|2018|322
Overview of LASSO-related penalized regression methods for quantitative trait mapping and genomic selection
|Theoretical and Applied Genetics|2012|288
Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer
|Gut|2020|221
Chinese Consensus Report on Family-Based<i>Helicobacter pylori</i>Infection Control and Management (2021 Edition)
|Gut|2021|183